(Q41546286)

3 October 2017

1 reference

title

Histamine in cancer immunotherapy (English)

1 reference

ORCID Public Data File 2021

3 October 2017

1 reference

1 reference

author name string

Hellstrand K

1

1 reference

3 October 2017

Hermodsson S

2

1 reference

3 October 2017

Brune M

3

1 reference

3 October 2017

Naredi P

4

1 reference

3 October 2017

Carneskog J

5

1 reference

3 October 2017

Mellqvist UH

6

1 reference

3 October 2017

1 May 1997

1 reference

Scandinavian Journal of Clinical and Laboratory Investigation

3 October 2017

1 reference

3 October 2017

57

1 reference

3 October 2017

3

1 reference

3 October 2017

193-202

1 reference

Cytokine therapeutics: lessons from interferon alpha

3 October 2017

1 reference

https://api.crossref.org/works/10.3109%2F00365519709060027

Interferon-alpha in malignant and viral diseases. A review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365519709060027

Biology of natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365519709060027

Histaminergic regulation of NK-cells: protection against monocyte-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365519709060027

Regression of established pulmonary metastases and subcutaneous tumor mediated by the systemic administration of high-dose recombinant interleukin 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365519709060027

Phase II study of intravenous bolus recombinant interleukin-2 in advanced malignant melanoma: Southwest Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365519709060027

Androgen therapy in myelodysplastic syndromes with thrombocytopenia: a report on 20 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365519709060027

Strategies in the treatment of acute myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365519709060027

Acute myelogenous leukemia: current treatment and future directions.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365519709060027

Inducibility of lymphokine activated killer (LAK) cells in patients with acute myelogenous leukaemia in complete remission and its clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365519709060027

Recombinant interleukin 2 for acute myeloid leukaemia in first complete remission: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365519709060027

10.3109/00365519709060027

21 January 2018

Identifiers

DOI

1 reference

3 October 2017

1 reference